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j Abstract The use of electro-
convulsive therapy (ECT) in ado-
lescents is controversial, and few
studies have been conducted to
assess its efficacy and safety in this
population. We report the case of
a 19-year-old boy who received
two series of ECT, one at 15 and
another at 16, for intractable cat-
atonic schizophrenia. Since the
age of 17, he has required treat-
ment combining clozapine and
maintenance ECT. The course
showed a sustained moderate
improvement. The treatment
permitted the patient to regain
some autonomy with moderate
adverse effects. ECT remains an
uncommon treatment in adoles-
cents, and the current case sup-
ports the view that it should not be
banned in young people.
j Key words catatonic schizo-
phrenia – adolescent –
electro-convulsive therapy –
maintenance ECT
Introduction
The use of electro-convulsive therapy (ECT) in ado-
lescents was first reported by Heuyer et al. in 1942. It
has become very rare since the appearance of anti-
psychotic drugs, and its frequency is now estimated to
range between 0.5 and 1 adolescent per million every
year [15]. Several reports showed that ECT can be a
safe and effective treatment for adolescents with
intractable mood disorders, in particular when pa-
tients exhibit catatonic or psychotic symptoms. ECT
may also be appropriate for some patients with
resistant schizophrenia [7, 14, 20, 21, 24–27, 29, 31,
38]. However, some authors [5, 6] have raised ethical
concerns and alleged unknown secondary cognitive
effects to ban ECT use in adolescents. This negative
point of view toward the use of ECT in this age group
is also codified in the laws of several states in the US
[19]. The use of ECT in minors has been prohibited by
legislation in California (1974; for minors under age
12), Tennessee (1976; under age 14), Colorado (1977;
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under age 15), and more recently Texas (1993; under
age 16). However, both the American Psychiatric
Association [3] and the American Academy of Child
and Adolescent Psychiatry [22] do not consider age as
a contraindication. In France, the use of ECT in
teenagers is not prohibited, and guidelines are very
similar to those formulated by the APA [1].
Here, we report the case of an adolescent with
intractable catatonic schizophrenia for whom main-
tenance ECT, given since age 17, resulted in moderate
symptom improvement.
Case report
j History and psychiatric assessment
J., a 14-year-old European male patient, was hospita-
lised in the Department of Child and Adolescent
Psychiatry at Pitie´-Salpe´trie`re Hospital due to severe
behavioural symptoms including school refusal with
insidious onset. Family history and patient’s history
were unremarkable. The diagnosis of catatonic
schizophrenia was accepted for this patient; psychotic
symptoms included auditory and tactile hallucina-
tions, ‘‘echophenomena’’, and delusions of persecu-
tion; catatonic symptoms included automatic
compulsive movements secondary to hallucinations,
stereotypies, verbigeration, negativism, periodic psy-
chomotor excitement, and refusal to eat. We also
observed incontinence and social withdrawal. At
admission, the patient was scored on the clinical
global impression-severity (CGI-S) and the global
assessment of functioning scale (GAF). We also used
the modified Bush-Francis Catatonia rating scale [9,
13], in which each catatonic symptom was rated on a
scale from 0 to 3, leading to a maximum score of 60.
The CGI-S score at entry was 7, the GAF score was 10,
and the Catatonia rating scale score was 18. Extensive
laboratory evaluations, including LCR examination
and diagnostic imaging, were all unremarkable. Ade-
quate trials of lorazepam (5 mg/day), amisulpiride
(1,200 mg/day), thioridazine (30 mg/day), haloperidol
(10 mg/day), olanzapine (20 mg/day), and flupentixol
(60 mg/day), alone or in combination, yielded mini-
mal response with significant adverse effects, in par-
ticular extra-pyramidal symptoms and sedation. The
patient also received pack therapy1 (two sessions per
week for eight consecutive weeks), an adjuvant treat-
ment used for severe psychotic states in children and
adolescents [11, 12], also with no improvement.
j ECT parameters
Because the patient’s symptoms persisted with se-
vere impairment and poor autonomy, the use of
ECT was considered. This was discussed with both
parents extensively. After the patient’s and his par-
ents’ consent, we started a course of ECT. All other
treatments were discontinued. Anaesthesia for ECT
was induced using intravenous propofol (60–
250 mg, mean 173 mg), and muscle relaxation was
achieved with intravenous suxamethonium (50–
100 mg, mean 63 mg). ECT was administered using
a Thymatron-IV device that produces a brief pulse
electric current (pulse width 1.0 ms, pulse duration
3.2 s) with a 30–70 Hz frequency. The electrical
stimulus was applied using the standard bilateral
electrode position with 10–30% energy (0.75–
0.92 A). Consecutive pulses ended when a seizure of
at least 30 s was elicited.
A course of 15 bilateral ECT treatments was first
administered. After the seventh session, the symp-
toms gradually decreased, reaching a GAF score of 41.
The catatonic symptoms paralleled GAF improve-
ment, as evidenced by a decrease in the patient’s
Catatonia rating scale score from 20 before ECT to 8
after ECT. This allowed the patient to be discharged
from the hospital. Treatment with olanzapine, 15 mg/
day, was started. The clinical improvement lasted one
month, but then the patient’s symptoms worsened,
requiring a second hospitalisation. The patient first
received increasing doses of clozapine up to 450 mg/
day with blood monitoring, but showed no improve-
ment and sedation. A second course of 20 ECT ses-
sions was administered after clozapine disruption.
Again, a moderate but clear improvement occurred
(Fig. 1). The patient refused to continue with main-
tenance ECT because of subjective memory impair-
ments. Clozapine was re-administered at a dosage of
300 mg/day.
Unfortunately, the patient did not maintain the
moderate improvement, and his condition again
worsened. After a second opinion from another Uni-
versity Department, he accepted maintenance ECT.
He was 17 years old when the treatment began. He
received eight acute ECT sessions, then continued
with maintenance ECT (once per week, then every
2 weeks, then every 4 weeks). Again, a moderate
improvement occurred, despite his condition
remaining severe. The patient was able to participate
in activities and regain autonomy. Figure 1 summa-
rises the course of the symptom severity relative to
ECT sessions. Residual symptoms included anxiety,
mild catatonic signs (automatic compulsive move-
ments and negativism) and social withdrawal. He
never returned to school or home and needed resi-
dential care for the following 3 years. He was able to
1Pack therapy: envelopment in damp sheets for 1 h sessions with
the patient expressing body and corporal feelings and spontaneous
fantasies. An example is given in case 2 of Cohen’s report [11].
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visit his family on weekends and to participate in
regular sessions of milieu therapy, including theatre.
j Monitoring of adverse effects
Adverse effects were monitored as recommended
[22]. In particular, cognitive assessments were given
before treatment, after acute ECT treatment, at 6 and
18 months during maintenance ECT. Table 1 sum-
marises the data. The quality of the assessment was
limited by the patient’s compliance with the testing
situation and negativism. Given these limitations, the
adverse effects, particularly memory impairment, re-
mained reasonable for our patient at 6 months, as
evidenced by global cognition and memory scores. At
18 months, the available data are limited to the mini-
mental state evaluation, the information sub-score of
the Weschler adult intelligence scale and the story
sub-score of the Wechsler memory scale, because the
patient refused to repeat the testing.
Assessment of subjective memory impairment was
performed using the Squire’s subjective memory
questionnaire (SSMQ), in which a score very close to
0 indicates that the patient judges his current memory
to be neither worse nor better than before the ECT.
After the first course of ECT, the ECT sub-score, the
Depression sub-score and the total score were )32,
)8, and )40, respectively, indicating marked sub-
jective memory impairment as a consequence of ECT
[30]. Although the patient refused to complete the
SSMQ again during maintenance ECT, he complained
of memory impairments due to ECT. Other secondary
effects included mild headaches following some ECT
sessions.
Discussion
To our knowledge, we report the first recent case of
maintenance ECT in a young person with catatonic
schizophrenia. Two recent papers reported the use of
‘‘maintenance’’ ECT in catatonia comorbid with aut-
ism [4, 37]. However, in these cases the maintenance
Table 1 Cognitive assessment
before, after and during
maintenance ECT
Acute ECT Maintenance ECT
Baseline After ECT 6 months 18 months
Cumulative number of ECT 0 20 32 61
Global cognition
MMS 25 24 26 27
Informationa 8/10 8/10 8/10 6/10
Block designa 9/10 7/10 8/10 Refusal
Memoryb
Story 8 8 6 3
Pair of words 6 4 5 Refusal
Words list 7 6 6 Refusal
Number remind 10 7 8 Refusal
Rey figure
Copy organisation Type 1 Type 1 Type 1 Refusal
Copy accuracy 34 (70 cent) 30 (50 cent) 34 (60 cent) Refusal
Delayed organisation Type 1 Type 1 Refusal Refusal
Delayed accuracy 24 (60 cent) 18 (60 cent) Refusal Refusal
SSMQ NA )40 Refusal Refusal
MMS mini-mental state, NA not appropriate, SSMQ Squire’s subjective memory questionnaire
aSubscore of the Wechsler intelligence scale for children-III-R for time 1 and 2, Wechsler adult intelligence scale for time 3
and 4
bChildren memory scale for time 1 and 2, Wechsler memory scale III for time 3 and 4
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Fig. 1 Global assessment functioning score course in a 19-year-old adolescent
treated with maintenance ECT since 17 years of age for intractable catatonic
schizophrenia
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phase was up to 6 months in Wachtel et al.’s report
and 27 weeks in Bailine et al.’s report, corresponding
to a consolidation phase with gradual tapering rather
than the typically longer time course of maintenance
ECT (in our case, 2 years) [19, 20]. In sum, the cur-
rent case illustrates that ECT is moderately effective in
treating symptoms of catatonic schizophrenia. The
course of symptom severity shows that: (a) ECT
moderately improved the patient’s symptom severity
on two distinct occasions; (b) antipsychotic medica-
tions, including olanzapine and clozapine, did not
maintain clinical improvement after ECT; and (c) on
the contrary, maintenance ECT with increasing time
between sessions allowed the moderate improvement
to stabilize (see Fig. 1).
The number of studies of ECT during adolescence
is low, and only three controlled studies exist [7, 15,
25]. Even though many controversies persist over the
use of ECT in youth, interest in the procedure is
growing [18]. Careful utilization is recommended, but
its efficacy in the treatment of severe and resistant
mood disorders and catatonic syndromes is ob-
servable [13]. A literature review from the first use of
ECT in children and adolescents in 1942 and 1996
estimated that a total of 396 patients under 18 years
old were treated with ECT, but most of the reviewed
studies only reported unique cases or very small
series [28]. According to this review, ECT treatment
was used for mood disorders in 72% of cases. A
substantial improvement or complete disappearance
of symptoms was seen in 53% of the subjects and in
70% of the mood disorder cases. We recently con-
ducted a meta-analysis of the nine retrospective
studies including ten or more patients that have been
published since 1993 [16]. Two of them were con-
trolled trials [7, 25]. This meta-analysis confirmed the
results obtained in Rey and Walter’s review [28]. In
particular, 9 of 11 patients (82%) treated with ECT for
a catatonic syndrome experienced improvement [16].
However, the first line treatment of catatonia is ben-
zodiazepine, which must be given in high dosages
(e.g., up to 20 mg/day of lorazepam) [20]. In our case,
sedation limited the use of such a high dosage.
ECT’s side effects in young people are rarely
studied. No deaths have been reported in adolescents
[22]. The theoretical risk is similar to that of brief
general anaesthesia. ECT side effects described in
adolescents include transient memory impairments,
prolonged seizures (more frequent in adolescents
than in adults) and tardive seizures, and other benign
and transitory effects (headaches, confused states,
nausea, muscular pains) [23, 38]. Eleven bipolar
adolescents treated for severe mood episodes under-
went a cognitive evaluation 4 years later on average
and were compared with adolescents matched for age,
sex and diagnosis and not treated with ECT. No
objective significant difference was found in long-
term anterograde memory or in academic delay, even
though subjective memory problems were reported by
two subjects from the ECT group [15, 32]. Further-
more, two groups studied patients’ and parents’
experiences and opinions concerning ECT in young
people [33, 39]. In general, the two studies showed
that patients and their parents had a positive attitude
toward ECT, even though the treatment frightened the
adolescents and their parents initially. The current
case confirms that ECT is a frightening treatment for
young people and that subjective memory impair-
ment is the main issue among the secondary effects. It
may be related to poor biographical memory that was
not assessed in the patient. Notably, ECT was a
complex decision for J’s parents, and we cannot ex-
clude the possibility that our ECT schedule was
occasionally disrupted by social and parental factors.
A therapeutic alliance with the family is crucial for
helping them make the decision, as parents may be a
source of anxiety.
Treatment of catatonia is mainly symptomatic, and
sedative drugs (in particular lorazepam) are the first
options [17, 36]. However, chronic presentations
prove to be more challenging to treat and have shown
poor responses to standard therapeutics in adult
studies [35]. ECT is a recommended option in resis-
tant cases [34]. This case supports the view that ECT
should not be banned in teens and that it is a thera-
peutic option in catatonia as well. Similarly, mainte-
nance ECT may be indicated in case of relapse of a
condition that responded to an ECT course, including
mood disorders and schizophrenia [2, 8, 10]. This
case illustrates the importance of maintenance ECT as
a treatment option in adolescents with severe psy-
chiatric conditions. More research to assess indica-
tions, technicity, effectiveness and safety is warranted.
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